Cyclenium Pharma
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
7171 Rue Frederick-banting Bureau 3309, ...Phone Number
(919) 313-4760Website
www.cyclenium.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cyclenium Pharma
Cyclenium Pharma, a Canadian subsidiary of SpiroChem AG, specializes in proprietary next-generation small-molecule technology for drug discovery targeting challenging disease conditions. As a Contract Research Organization, it provides innovative solutions to pharmaceutical and biotechnology companies globally, focusing on macrocycles as new therapeutic modalities. Founded by experts from Tranzyme Pharma, Cyclenium leverages extensive experience in macrocyclic chemistry to enhance drug discovery efforts. The company has established collaborations with various international partners to advance its research and development initiatives.Explore more
Cyclenium Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cyclenium Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cyclenium Pharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Cyclenium Pharma
Check if Cyclenium Pharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Cyclenium Pharma recently announced quarterly report
Product Launch: Get notified when Cyclenium Pharma launches new products
Check out if Cyclenium Pharma is spiking on competitors!
Cyclenium Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Cyclenium Pharma had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Cyclenium Pharma as Masked Content
Find 3 more new buyers
Compare Similar Companies to Cyclenium Pharma
Compare insights from companies similar to Cyclenium Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cyclenium Pharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cyclenium Pharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cyclenium Pharma.
Cyclenium Pharma Tech Stack
A closer look at the technologies used by Cyclenium Pharma
Cyclenium Pharma News & Media
Cyclenium Pharma and Vuja De Sciences Announce Oncology Drug Discovery Collaboration
NATICK, Mass. & HOBOKEN, N.J. & MONTREAL--(BUSINESS WIRE)--New drug discovery collaboration combining the unique screening technology of Vuja De with the proprietary macrocycle technology of Cyclenium.AiCuris to Cooperate with Cyclenium Pharma to Develop Novel Anti-Infectives
WUPPERTAL, Germany & MONTREAL--(BUSINESS WIRE)--#Canadabiotech--AiCuris and Cyclenium Pharma entered into a collaboration agreement for the discovery of novel anti-infective therapeutics.Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases
MONTREAL & VIENNA--(BUSINESS WIRE)--#biobucks--Cyclenium Pharma and Haplogen receive prestigious Eureka label and funding to discover therapeutics against flaviviruses including dengue and Zika.Cyclenium Pharma Announces Drug Discovery Collaboration Agreement with Ono Pharmaceutical
MONTREAL--(BUSINESS WIRE)--#biobucks--Cyclenium Pharma Inc., an emerging pharmaceutical company specializing in the discovery and development of novel therapeutic agents based on their proprietary macrocyclic chemistry, announced today the signing of a drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd., a leading Japanese pharmaceutical research and development company. The collaboration will exploit Cyclenium’s proprietary QUEST Library™ of next generation synthetic small-
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cyclenium Pharma
Sign Up For FreeTo access detailed company insights
Cyclenium Pharma, a Canadian subsidiary of SpiroChem AG, specializes in proprietary next-generation small-molecule technology for drug discovery targeting challenging disease conditions. As a Contract Research Organization, it provides innovative solutions to pharmaceutical and biotechnology companies globally, focusing on macrocycles as new therap... Read More
